Prevalence of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae in Trakya University Hospital, Turkey

New Microbiologica

Volumn 26, Issue 3, 2003, Pages 257-262

  Akata, F ^a   Tatman Otkun, M ^a   Ozkan E ^a   Tansel, O ^a   Otkun, M ^a   Tugrul, M ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Enterobacteriaceae; ESBL; Isoelectric point; Klebsiella pneumoniae; Plasmid

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL ENZYME; BETA LACTAM; BETA LACTAMASE; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREVALENCE; PROVIDENCIA RETTGERI; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL; BACTERIUM CONJUGATION; CROSS INFECTION; ENTEROBACTER INFECTION; ENZYMOLOGY; GENETICS; HUMAN; ISOELECTRIC POINT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; PROVIDENCIA RETTGERI;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CONJUGATION, GENETIC; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; ISOELECTRIC POINT; MICROBIAL SENSITIVITY TESTS; PREVALENCE; TURKEY;

EID: 0142008883     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BINGEN, E. (1994). Applications of molecular methods to epidemiologic investigations of nosocomial infections in a pediatric hospital. Infection Control and Hospital Epidemiology, 15, 488-493.
2. CORMICAN, M.G., MARSHALL, S.A., and JONES, R.N. (1996). Detection of extended-spectrum beta-lactamase (ESBL)-producing strains in the Etest ESBL screen. Journal of Clinical Microbiology, 34, 1880-1884.
3. DE CHAMPS, C., SIROT, D., CHANAL, C., BONNET, R., SIROT, J., and THE FRENCH STUDY GROUP. (2000). A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. Antimicrobial Agents and Chemotherapy, 44, 3177-3179.
4. FARMER, J.J.III. (1995). Enterobacteriaceae: Introduction and identification. In: Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H. Eds, Manual of Clinical Microbiology. Sixth Edition. American Society for Microbiology, Washington, D.C. (USA).
5. GARNER, J.S., JARWIS, W.R., EMORY, T.G., HORAN, T.C., and HUGHES, J.M. (1988). CDC definitions for nosocomial infections. American Journal of Infection Control, 16, 128-140.
6. JARLIER, V., NICHOLAS, M.H., FOURNIER, G., AND PHILIPPON, A. (1988). Extended-broad spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalance and susceptibility patterns. Reviews of Infectious Diseases, 10, 867-878.
7. KADO, C.I., and LIU, S.T. (1981). Rapid procedure for detection and isolation of large and small plasmids. Journal of Bacteriology, 145, 1365-1373.
8. LIVERMORE, D.M. (1995). Beta-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews, 8, 557-584.
9. LIVERMORE, D.M., and YUAN, M. (1996). Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. Journal of Antimicrobial Chemotherapy, 38, 409-424.
10. MARTINEZ-MARTINEZ, L., PASCUAL, A., and JACOBY, G.A. (1998). Quinolone resistance from a transferable plasmid. The Lancet, 351, 797-799.
11. MATTHEW, M., HARRIS, A.M., MARSHALL, M.J., and ROSS, G.W. (1975). The use of analytic isoelectric focusing for detection and identification of beta-lactamases. Journal of General Microbiology, 88, 169-178.
12. MENASHE, G., BORER, A., YAGUPSKY, P., PELED, N., GILAD, J., FRASER, D., RIESENBERG, K., and SCHLAEFFER, F. (2001). Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. Scandinavian Journal of Infectious Diseases, 33, 188-193.
13. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. (1999). Performance Standards for Antimicrobial Susceptibility Testing. Ninth Informational Supplement. NCCLS Document M100-S9, Pennsylvania (USA).
14. PATERSON, D.L., MÜLAZIMOGLU, L., CASELLAS, J.M., KO, W-C., GOOSSENS, H., GOTTBERG, A.V., MOHAPATRA, S., TRENHOLME, G.M., KLUGMAN, K.P., MCCORMACK, J.G., and YU, V.L. (2000). Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clinical Infectious Diseases, 30, 473-478.
15. SIROT, J. (1996). Detection of extended-spectrum plasmid mediated beta-lactamases by disk diffusion. Clinical Microbiology and Infection, 2 (Suppl 1), 35-39.
16. SPANU, T., LUZZARO, F., PERILLI, M., AMICOSANTE, G., TONIOLO, A., FADDA, G., and THE ITALIAN ESBL STUDY GROUP. (2002). Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrobial Agents and Chemotherapy, 46, 196-202.
17. VAHABOGLU, H., DODANLI, S., EROGLU, C., ÖZTÜRK, R., SÖYLETIR. G., YILDIRIM, I., and AVKAN, V. (1996). Characterization of multiple-antibiotic-resistant Salmonella typhimurium strains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone. Journal of Clinical Microbiology, 34, 2942-2946.
18. WINOKUR, P.L., CANTON, R., CASELLAS, J.M., and LEGAKIS, N. (2001). Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pasific Region. Clinical Infectious Diseases, 32 (Suppl 2), 94-103.
19. YUAN, M., AUCKEN, H., HALL, L.M.C., PITT, T.L., and LIVERMORE, D.M. (1998). Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. Journal of Antimicrobial Chemotherapy, 41, 527-539.